Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets Manufacturer, Supplier, and Exporter in India

Taj Pharma is a leading manufacturer, supplier, and exporter of Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets in India, providing assured quality and therapeutic effectiveness. With WHO-GMP certified and ISO 9001:2015 approved manufacturing facilities located in Vapi, Gujarat and Mumbai, Maharashtra, Taj Pharma ensures global standard production and distribution of HIV antiretroviral formulations.

We are committed to supplying affordable and reliable HIV treatment medications to both domestic and international markets, making us a trusted global partner for healthcare providers, NGOs, and government institutions.


πŸ’Š Overview: Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets

Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets are a fixed-dose combination antiretroviral medication designed for the management of Human Immunodeficiency Virus (HIV-1) infection.

This combination includes:

  • Darunavir Ethanolate (800mg): A protease inhibitor that prevents viral replication.
  • Ritonavir (100mg): A pharmacokinetic enhancer that boosts Darunavir’s effectiveness by slowing its metabolism.

Together, they inhibit the protease enzyme required for viral replication, effectively reducing the HIV viral load and improving the patient’s immune function.


🏭The Trusted Manufacturer of Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets

Taj Pharma has established itself as one of India’s top pharmaceutical manufacturers, producing Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets with a focus on safety, efficacy, and affordability. Our world-class facilities are equipped with advanced R&D laboratories, automated production lines, and in-house quality testing units to ensure unmatched consistency in every batch.

πŸ”Ή Key Manufacturing Strengths:

βœ” WHO-GMP & ISO 9001:2015 Certified Units
βœ” Highly Skilled Technical Team
βœ” Robust Quality Control (QC) and Quality Assurance (QA)
βœ” Regulatory Compliance with Global Standards
βœ” Flexible Contract Manufacturing & Private Label Services

Every stage of manufacturing, from raw material procurement to final packaging, undergoes strict quality verification, ensuring purity, potency, and stability.


🌍 PAN India Distribution and Global Export

Taj Pharma serves as a PAN India supplier of Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets, ensuring timely and reliable supply across all major states β€” Delhi, Maharashtra, Gujarat, Tamil Nadu, Telangana, and Karnataka.

We are also a recognized global exporter, with strong trade ties across Africa, the Middle East, Asia-Pacific, CIS, and Latin America. Our export operations comply with international regulatory standards such as WHO, EMA, and USFDA-equivalent norms.

🌐 Export Regions Include:
India | Nigeria |South Africa |Philippines |Bangladesh |Nepal |Iraq |UAE |Saudi Arabia |Kenya


πŸ§ͺ Composition & Specifications

Active IngredientStrengthTherapeutic Role
Darunavir Ethanolate800 mgHIV-1 Protease Inhibitor
Ritonavir100 mgCYP3A Inhibitor (Pharmacokinetic Booster)

Form: Film-coated oral tablets
Packaging Type: Alu-Alu Blister / HDPE Container
Pack Size: 30 or 60 Tablets per pack
Shelf Life: 24 months


βš•οΈ Mechanism of Action

Darunavir Ethanolate binds to the HIV-1 protease enzyme, preventing the cleavage of viral polyproteins necessary for the formation of mature virus particles. This action halts the virus replication process.

Ritonavir, a CYP3A inhibitor, enhances the plasma concentration of Darunavir by slowing its breakdown in the liver, ensuring sustained therapeutic levels.

Together, they provide powerful viral suppression, helping patients maintain a low viral load and improving long-term immune function.


🩺 Indications and Usage

Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets are indicated for:
βœ” Treatment of HIV-1 infection in adults and adolescents aged β‰₯12 years
βœ” Combination therapy with other antiretroviral agents
βœ” Highly Active Antiretroviral Therapy (HAART) regimens

This fixed-dose therapy offers convenience, improved adherence, and long-term viral suppression when taken consistently under medical supervision.


πŸ’‘ Dosage and Administration

  • Recommended Dose: One tablet (Darunavir 800mg + Ritonavir 100mg) once daily with food.
  • Administration: Oral; must be used in combination with other antiretroviral agents.
  • Missed Dose: Take as soon as possible unless it’s almost time for the next dose.

πŸ“Œ Strict adherence to dosage is essential to prevent drug resistance.


⚠️ Warnings and Precautions

⚠️ For prescription use only under the supervision of a qualified healthcare professional.
⚠️ Do not combine with medications that strongly induce CYP3A enzymes.
⚠️ Use caution in patients with hepatic impairment.
⚠️ Avoid alcohol consumption during therapy.

Common Side Effects:

  • Nausea and Vomiting
  • Headache
  • Abdominal Pain
  • Diarrhea
  • Increased Cholesterol/Triglycerides
  • Mild Skin Rash

Most side effects are mild and temporary; consult your physician if symptoms persist.


πŸ’° Best Price Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets

At Taj Pharma, we offer competitive pricing for Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets without compromising quality. As one of the leading pharmaceutical manufacturers in India, we provide cost-effective solutions for government tenders, NGOs, hospitals, and global procurement agencies.

πŸ’  Key Advantages:
βœ” Bulk Supply at Factory-Direct Prices
βœ” Global Export-Quality Standards
βœ” On-Time Delivery
βœ” Private Label Manufacturing
βœ” Transparent Dealings


🀝 PCD Pharma Franchise Opportunity for Darunavir Ethanolate & Ritonavir Tablets

Taj Pharma invites PCD Pharma Franchise distributors across India for Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets.

Franchise Benefits Include:

⭐ Monopoly Rights by Region
⭐ High Profit Margins
⭐ Promotional & Marketing Support
⭐ Product Training & Guidance
⭐ Timely Product Availability

Join India’s leading pharma franchise network and grow your business with Taj Pharma’s trusted HIV formulations.


🌐 Why Choose Taj Pharma for Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets?

FeatureTaj Pharma Advantage
WHO-GMP Certified FacilitiesEnsures uncompromised quality
In-House R&D & Formulation ExpertsInnovative, patient-friendly drugs
PAN India & Global Supply ChainFast, reliable delivery
Regulatory ComplianceWHO, GMP, ISO Certified
Affordable PricingAccessible healthcare for all

Our reputation as India’s No.1 Darunavir Ethanolate & Ritonavir Tablets Manufacturer stems from our commitment to global healthcare and ethical business practices.


πŸ“¦ Packaging, Quality & Shelf Life

Taj Pharma focuses on premium pharmaceutical packaging that ensures product stability, protection, and long shelf life.

πŸ“¦ Packaging Options:

  • Alu-Alu Blister Packs
  • HDPE Bottles
  • Customized Export Packing

All packaging is tamper-proof, moisture-resistant, and compliant with global standards.

πŸ•’ Shelf Life: 24 months from the date of manufacture under controlled storage conditions.


🌎 Export Expertise and Regulatory Approvals

Taj Pharma exports Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets under stringent regulatory and documentation compliance, meeting the requirements of:

  • WHO-GMP, cGMP, and ISO standards
  • Dossier Support (CTD/eCTD)
  • COA, MOA, and Stability Data

Our reputation as a trusted exporter makes us a preferred partner for international tender supplies, NGOs, and institutional buyers.

πŸ“ž Contact Taj Pharma India

For bulk supply, contract manufacturing, or franchise inquiries, reach out to:

Taj Pharma India Ltd.
🏭 Manufacturing Unit: Vapi, Gujarat
πŸ“ Corporate Office: Mumbai, Maharashtra
🌐 Website: www.tajpharma.in
πŸ“§ Email: info@tajpharma.com


Taj Pharma stands at the forefront as a trusted manufacturer, supplier, and exporter of Darunavir Ethanolate & Ritonavir 800mg/100mg Tablets in India, ensuring consistent quality, affordability, and therapeutic efficacy. With a robust manufacturing infrastructure and an ethical approach to business, we remain dedicated to improving global access to life-saving HIV treatments.